Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION

Last updated on 2020-04-07 History
Report ID 110220
Drug Identification Number 02362627
Brand name PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Common or Proper name PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) PIPERACILLIN TAZOBACTAM
Strength(s) 3.000G 0.375G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 VIALS
ATC code J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-03-17
Estimated end date Unknown
Actual end date 2020-04-07
Shortage status Resolved
Updated date 2020-04-07
Company comments
Health Canada comments
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-04-07 French Compare
v3 2020-04-07 English Compare
v2 2020-03-31 French Compare
v1 2020-03-31 English Compare